Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 1,636,500 | 1,591,800 | 1,588,700 | 1,444,600 | 1,444,800 |
| Cost of Goods | 125,400 | 152,200 | 144,700 | 144,900 | 111,700 |
| Gross Profit | 1,511,100 | 1,439,600 | 1,444,000 | 1,299,700 | 1,333,100 |
| Operating Expenses | 875,300 | 817,700 | 759,800 | 2,670,800 | 638,300 |
| Operating Income | 636,200 | 622,100 | 684,900 | -1,370,200 | 695,500 |
| Interest Expense | 27,100 | 27,700 | 27,600 | 23,600 | 25,800 |
| Other Income | -6,500 | -3,800 | 9,600 | 41,700 | -6,100 |
| Pre-tax Income | 602,600 | 590,600 | 666,900 | -1,352,100 | 663,600 |
| Income Tax | 113,400 | 54,800 | 88,800 | -284,000 | 106,000 |
| Net Income Continuous | 489,200 | 535,800 | 578,100 | -1,068,100 | 557,600 |
| Minority Interests | -146,800 | N/A | N/A | N/A | N/A |
| Net Income | $636,000 | $535,800 | $578,100 | $-1,068,100 | $557,600 |
| EPS Basic Total Ops | 2.89 | 2.42 | 2.64 | -4.84 | 2.52 |
| EPS Basic Continuous Ops | 2.22 | 2.43 | 2.64 | -4.84 | 2.52 |
| EPS Diluted Total Ops | 2.86 | 2.44 | 2.62 | -4.84 | 2.50 |
| EPS Diluted Continuous Ops | 2.20 | 2.43 | 2.62 | -4.84 | 2.50 |
| EPS Diluted Before Non-Recurring Items | 3.25 | 2.72 | 3.07 | 2.87 | 3.02 |
| EBITDA(a) | $711,800 | $697,200 | $760,100 | $772,900 | $784,800 |